Rank | Gene Set | Z-score |
---|---|---|
1 | regulation of RIG-I signaling pathway (GO:0039535) | 6.73662686 |
2 | eosinophil chemotaxis (GO:0048245) | 6.72299465 |
3 | eosinophil migration (GO:0072677) | 6.03469406 |
4 | regulation of vitamin D biosynthetic process (GO:0060556) | 5.67457696 |
5 | NIK/NF-kappaB signaling (GO:0038061) | 5.64387907 |
6 | regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway (GO:0039531) | 5.64272576 |
7 | regulation of chronic inflammatory response (GO:0002676) | 5.58510433 |
8 | regulation of fever generation (GO:0031620) | 5.33281068 |
9 | regulation of cytokine secretion involved in immune response (GO:0002739) | 4.86717940 |
10 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 4.83409566 |
11 | regulation of vitamin metabolic process (GO:0030656) | 4.79067815 |
12 | myoblast migration (GO:0051451) | 4.77227490 |
13 | response to interferon-alpha (GO:0035455) | 4.54314599 |
14 | regulation of heat generation (GO:0031650) | 4.19556730 |
15 | regulation of mononuclear cell migration (GO:0071675) | 4.09172190 |
16 | positive regulation of natural killer cell differentiation (GO:0032825) | 4.07047120 |
17 | cellular response to type I interferon (GO:0071357) | 4.05713830 |
18 | type I interferon signaling pathway (GO:0060337) | 4.05713830 |
19 | oxygen transport (GO:0015671) | 4.04074945 |
20 | positive regulation of antigen processing and presentation (GO:0002579) | 4.02323497 |
21 | negative regulation of interleukin-12 production (GO:0032695) | 4.00601414 |
22 | regulation of activation of Janus kinase activity (GO:0010533) | 4.00547801 |
23 | response to type I interferon (GO:0034340) | 3.96316876 |
24 | positive regulation of chemokine biosynthetic process (GO:0045080) | 3.95832425 |
25 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 3.88286092 |
26 | branching involved in labyrinthine layer morphogenesis (GO:0060670) | 3.87047772 |
27 | regulation of T-helper 1 cell differentiation (GO:0045625) | 3.81434233 |
28 | mitotic metaphase plate congression (GO:0007080) | 3.81079430 |
29 | regulation of immunoglobulin secretion (GO:0051023) | 3.80844777 |
30 | cellular response to virus (GO:0098586) | 3.78448038 |
31 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 3.72032083 |
32 | regulation of transforming growth factor beta2 production (GO:0032909) | 3.71120726 |
33 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.69504025 |
34 | regulation of chemokine biosynthetic process (GO:0045073) | 3.68528515 |
35 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.67825117 |
36 | regulation of podosome assembly (GO:0071801) | 3.66615376 |
37 | positive regulation of defense response to virus by host (GO:0002230) | 3.66034669 |
38 | positive regulation of interleukin-12 production (GO:0032735) | 3.60943123 |
39 | regulation of female gonad development (GO:2000194) | 3.55727019 |
40 | cellular response to ATP (GO:0071318) | 3.55173337 |
41 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 3.54621216 |
42 | germinal center formation (GO:0002467) | 3.52350434 |
43 | positive regulation of type 2 immune response (GO:0002830) | 3.51932401 |
44 | negative regulation of hormone metabolic process (GO:0032351) | 3.48381418 |
45 | negative regulation of hormone biosynthetic process (GO:0032353) | 3.48381418 |
46 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.46152244 |
47 | regulation of antigen processing and presentation (GO:0002577) | 3.44998224 |
48 | immunoglobulin mediated immune response (GO:0016064) | 3.44679484 |
49 | regulation of Cdc42 GTPase activity (GO:0043088) | 3.44657114 |
50 | macrophage activation involved in immune response (GO:0002281) | 3.42045369 |
51 | cellular response to interferon-alpha (GO:0035457) | 3.41464216 |
52 | positive regulation of cAMP-mediated signaling (GO:0043950) | 3.40419413 |
53 | myeloid dendritic cell differentiation (GO:0043011) | 3.37253521 |
54 | DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 cla | 3.34899300 |
55 | positive regulation of nitric oxide biosynthetic process (GO:0045429) | 3.34433065 |
56 | piRNA metabolic process (GO:0034587) | 3.33806535 |
57 | defense response to protozoan (GO:0042832) | 3.33531902 |
58 | response to protozoan (GO:0001562) | 3.33235291 |
59 | regulation of nitric oxide biosynthetic process (GO:0045428) | 3.33183325 |
60 | negative regulation of inflammatory response to antigenic stimulus (GO:0002862) | 3.31885831 |
61 | DNA damage response, signal transduction resulting in transcription (GO:0042772) | 3.31792905 |
62 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.31641879 |
63 | regulation of T-helper cell differentiation (GO:0045622) | 3.31122832 |
64 | positive regulation of megakaryocyte differentiation (GO:0045654) | 3.30093388 |
65 | chronic inflammatory response (GO:0002544) | 3.29330770 |
66 | indole-containing compound catabolic process (GO:0042436) | 3.25380310 |
67 | indolalkylamine catabolic process (GO:0046218) | 3.25380310 |
68 | tryptophan catabolic process (GO:0006569) | 3.25380310 |
69 | negative regulation of cytokine production involved in immune response (GO:0002719) | 3.25304597 |
70 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 3.23098797 |
71 | response to muramyl dipeptide (GO:0032495) | 3.22229456 |
72 | positive regulation of interferon-alpha production (GO:0032727) | 3.21445182 |
73 | negative regulation of viral genome replication (GO:0045071) | 3.21351002 |
74 | negative regulation of nitric oxide biosynthetic process (GO:0045019) | 3.20148058 |
75 | regulation of interleukin-8 biosynthetic process (GO:0045414) | 3.19117284 |
76 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.16844572 |
77 | regulation of membrane protein ectodomain proteolysis (GO:0051043) | 3.16794530 |
78 | positive regulation of acute inflammatory response (GO:0002675) | 3.14797391 |
79 | positive regulation of interleukin-1 beta production (GO:0032731) | 3.14697815 |
80 | negative regulation of homotypic cell-cell adhesion (GO:0034111) | 3.12428657 |
81 | female gamete generation (GO:0007292) | 3.11544501 |
82 | CD4-positive or CD8-positive, alpha-beta T cell lineage commitment (GO:0043369) | 3.10871844 |
83 | maturation of 5.8S rRNA (GO:0000460) | 3.09602754 |
84 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 3.08904256 |
85 | regulation of interleukin-1 secretion (GO:0050704) | 3.07020806 |
86 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 3.06240607 |
87 | female gonad development (GO:0008585) | 3.05029328 |
88 | regulation of interleukin-1 beta secretion (GO:0050706) | 3.03869568 |
89 | neutrophil activation involved in immune response (GO:0002283) | 3.03404267 |
90 | cellular response to nicotine (GO:0071316) | 3.02872803 |
91 | meiotic chromosome segregation (GO:0045132) | 3.02629325 |
92 | negative regulation of keratinocyte proliferation (GO:0010839) | 3.01211447 |
93 | regulation of T-helper 1 type immune response (GO:0002825) | 2.99878782 |
94 | regulation of inflammatory response to antigenic stimulus (GO:0002861) | 2.99754633 |
95 | cellular response to ethanol (GO:0071361) | 2.98252231 |
96 | positive regulation of hair follicle development (GO:0051798) | 2.98165900 |
97 | positive regulation of hair cycle (GO:0042635) | 2.98165900 |
98 | negative regulation of alcohol biosynthetic process (GO:1902931) | 2.97556818 |
99 | positive regulation of interleukin-1 beta secretion (GO:0050718) | 2.96504417 |
100 | intrinsic apoptotic signaling pathway in response to oxidative stress (GO:0008631) | 2.96111460 |
101 | myeloid dendritic cell activation (GO:0001773) | 2.95996662 |
102 | regulation of interferon-alpha production (GO:0032647) | 2.95915666 |
103 | response to nerve growth factor (GO:1990089) | 2.95434040 |
104 | cellular response to nerve growth factor stimulus (GO:1990090) | 2.95434040 |
105 | kynurenine metabolic process (GO:0070189) | 2.95217218 |
106 | positive regulation of interferon-gamma biosynthetic process (GO:0045078) | 2.95059039 |
107 | cellular response to gamma radiation (GO:0071480) | 2.94993508 |
108 | cellular response to exogenous dsRNA (GO:0071360) | 2.94790028 |
109 | positive regulation of granulocyte macrophage colony-stimulating factor production (GO:0032725) | 2.93991321 |
110 | regulation of interferon-gamma biosynthetic process (GO:0045072) | 2.93903077 |
111 | metaphase plate congression (GO:0051310) | 2.93482955 |
112 | positive regulation of hematopoietic progenitor cell differentiation (GO:1901534) | 2.92591543 |
113 | dendritic cell differentiation (GO:0097028) | 2.91715457 |
114 | regulation of meiosis (GO:0040020) | 2.91611416 |
115 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 2.91356033 |
116 | positive regulation of interleukin-6 production (GO:0032755) | 2.91217283 |
117 | positive regulation of interferon-beta production (GO:0032728) | 2.90637450 |
118 | cilium or flagellum-dependent cell motility (GO:0001539) | 2.90254147 |
119 | positive regulation of NF-kappaB import into nucleus (GO:0042346) | 2.90181435 |
120 | cellular response to lipopolysaccharide (GO:0071222) | 2.89773836 |
121 | positive regulation of interleukin-1 production (GO:0032732) | 2.88738119 |
122 | nerve growth factor signaling pathway (GO:0038180) | 2.87757082 |
123 | growth hormone receptor signaling pathway (GO:0060396) | 2.87598077 |
124 | oligosaccharide catabolic process (GO:0009313) | 2.86369986 |
125 | regulation of hypersensitivity (GO:0002883) | 2.85982549 |
126 | positive regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043372) | 2.84711785 |
127 | positive regulation of T-helper cell differentiation (GO:0045624) | 2.84263703 |
128 | Rap protein signal transduction (GO:0032486) | 2.83843247 |
129 | positive regulation of toll-like receptor signaling pathway (GO:0034123) | 2.83580444 |
130 | response to ATP (GO:0033198) | 2.83212769 |
131 | negative regulation of production of molecular mediator of immune response (GO:0002701) | 2.82003564 |
132 | regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043370) | 2.81987240 |
133 | regulation of interleukin-12 production (GO:0032655) | 2.81405251 |
134 | negative regulation of retinoic acid receptor signaling pathway (GO:0048387) | 2.81094195 |
135 | regulation of tyrosine phosphorylation of Stat1 protein (GO:0042510) | 2.81035661 |
136 | cellular response to molecule of bacterial origin (GO:0071219) | 2.80348938 |
137 | regulation of heterotypic cell-cell adhesion (GO:0034114) | 2.79646614 |
138 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.79451940 |
139 | cellular response to interferon-gamma (GO:0071346) | 2.78525335 |
140 | cellular biogenic amine catabolic process (GO:0042402) | 2.78493668 |
141 | amine catabolic process (GO:0009310) | 2.78493668 |
142 | regulation of defense response to virus by host (GO:0050691) | 2.78205667 |
143 | regulation of glucocorticoid metabolic process (GO:0031943) | 2.78079784 |
144 | meiotic cell cycle (GO:0051321) | 2.77126680 |
145 | interferon-gamma secretion (GO:0072643) | 2.76562786 |
146 | monocyte chemotaxis (GO:0002548) | 2.76341398 |
147 | positive regulation of humoral immune response (GO:0002922) | 2.75771088 |
148 | regulation of granulocyte macrophage colony-stimulating factor production (GO:0032645) | 2.74276108 |
149 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 2.74256604 |
150 | regulation of natural killer cell differentiation (GO:0032823) | 2.73917260 |
151 | negative regulation of growth of symbiont in host (GO:0044130) | 2.73124387 |
152 | negative regulation of growth of symbiont involved in interaction with host (GO:0044146) | 2.73124387 |
153 | modulation of growth of symbiont involved in interaction with host (GO:0044144) | 2.73124387 |
154 | regulation of growth of symbiont in host (GO:0044126) | 2.73124387 |
155 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 2.72565305 |
156 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 2.72565305 |
157 | positive regulation of interleukin-1 secretion (GO:0050716) | 2.71746640 |
158 | protein K6-linked ubiquitination (GO:0085020) | 2.71207926 |
159 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 2.70996974 |
160 | establishment of chromosome localization (GO:0051303) | 2.68221795 |
161 | regulation of response to interferon-gamma (GO:0060330) | 2.68078195 |
162 | ERK1 and ERK2 cascade (GO:0070371) | 2.67742981 |
163 | response to peptidoglycan (GO:0032494) | 2.66261078 |
164 | attachment of spindle microtubules to kinetochore (GO:0008608) | 2.65633321 |
165 | B cell mediated immunity (GO:0019724) | 2.63081283 |
166 | positive regulation of interleukin-17 production (GO:0032740) | 2.62910289 |
167 | positive regulation of heat generation (GO:0031652) | 2.62487645 |
168 | detection of other organism (GO:0098543) | 2.62194790 |
169 | hemidesmosome assembly (GO:0031581) | 2.61715501 |
170 | T-helper 1 type immune response (GO:0042088) | 2.60281760 |
171 | negative regulation of lipid storage (GO:0010888) | 2.54497968 |
172 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 2.53479275 |
173 | regulation of interferon-gamma-mediated signaling pathway (GO:0060334) | 2.53039522 |
174 | oocyte maturation (GO:0001556) | 2.51790073 |
Rank | Gene Set | Z-score |
---|---|---|
1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 4.77602118 |
2 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 4.61964944 |
3 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 4.52161486 |
4 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 4.34213904 |
5 | * SMAD_19615063_ChIP-ChIP_OVARY_Human | 3.55277762 |
6 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 3.15425026 |
7 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 3.11983589 |
8 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 3.01780388 |
9 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.96103368 |
10 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 2.84677319 |
11 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 2.71795217 |
12 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 2.46267542 |
13 | GATA1_22025678_ChIP-Seq_K562_Human | 2.35970191 |
14 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 2.29259228 |
15 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.25180520 |
16 | * RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.21097684 |
17 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 2.13144397 |
18 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.04400500 |
19 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.76042946 |
20 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.71515150 |
21 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.68860748 |
22 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.66299140 |
23 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.66078988 |
24 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.59979747 |
25 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.59665710 |
26 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.56970940 |
27 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.55257322 |
28 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.55130297 |
29 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.53178022 |
30 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.52714172 |
31 | * NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.52006981 |
32 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.46186982 |
33 | CJUN_26792858_Chip-Seq_BT549_Human | 1.42587537 |
34 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.42383282 |
35 | * NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.39984519 |
36 | * NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.39984519 |
37 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.38975198 |
38 | TP53_16413492_ChIP-PET_HCT116_Human | 1.38265155 |
39 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.37849013 |
40 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.33909368 |
41 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.33575935 |
42 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 1.28709442 |
43 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.28124938 |
44 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 1.27467012 |
45 | NMYC_18555785_Chip-Seq_ESCs_Mouse | 1.26823434 |
46 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.26314924 |
47 | * AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.26018129 |
48 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.26007981 |
49 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.25915870 |
50 | STAT3_18555785_Chip-Seq_ESCs_Mouse | 1.24237542 |
51 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.23638548 |
52 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.22149324 |
53 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.21533217 |
54 | * CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.21341947 |
55 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.21286633 |
56 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.20961754 |
57 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 1.20693444 |
58 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.19419405 |
59 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.19248200 |
60 | RUNX1_26923725_Chip-Seq_HPCs_Mouse | 1.18831684 |
61 | STAT1_17558387_ChIP-Seq_HELA_Human | 1.18236682 |
62 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.17998156 |
63 | * POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.17931076 |
64 | * SOX2_18555785_Chip-Seq_ESCs_Mouse | 1.17697103 |
65 | * CMYC_18555785_Chip-Seq_ESCs_Mouse | 1.17519741 |
66 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.16332541 |
67 | * SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.16106110 |
68 | OCT4_18555785_Chip-Seq_ESCs_Mouse | 1.15589196 |
69 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.15255827 |
70 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 1.13230244 |
71 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.12656242 |
72 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.12356761 |
73 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.12112892 |
74 | KLF4_18555785_Chip-Seq_ESCs_Mouse | 1.11305714 |
75 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.11185811 |
76 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.11185811 |
77 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.10787664 |
78 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.10310489 |
79 | VDR_22108803_ChIP-Seq_LS180_Human | 1.08203821 |
80 | * TP53_18474530_ChIP-ChIP_U2OS_Human | 1.08192220 |
81 | * EBF1_22473956_ChIP-Seq_LYMPHODE_Mouse | 1.07777926 |
82 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.07475825 |
83 | CDX2_22108803_ChIP-Seq_LS180_Human | 1.07436825 |
84 | CEBPB_26923725_Chip-Seq_MESODERM_Mouse | 1.07407689 |
85 | P53_22387025_ChIP-Seq_ESCs_Mouse | 1.06730184 |
86 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.06242675 |
87 | TP63_23658742_ChIP-Seq_EP156T_Human | 1.06016211 |
88 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.05679919 |
89 | CTCF_18555785_Chip-Seq_ESCs_Mouse | 1.05044657 |
90 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 1.04727191 |
91 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.04059448 |
92 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 1.03995693 |
93 | ZFX_18555785_Chip-Seq_ESCs_Mouse | 1.03240952 |
94 | SMRT_27268052_Chip-Seq_Bcells_Human | 1.03018003 |
95 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.01956443 |
96 | ESRRB_18555785_Chip-Seq_ESCs_Mouse | 1.01760679 |
97 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.01548301 |
98 | GATA1_26923725_Chip-Seq_HPCs_Mouse | 1.01102355 |
99 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 0.99139789 |
100 | P300_18555785_Chip-Seq_ESCs_Mouse | 0.98306241 |
101 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.97988286 |
102 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.97863246 |
103 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.97850074 |
104 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 0.97708141 |
105 | KDM2B_26808549_Chip-Seq_REH_Human | 0.97060722 |
106 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.96286401 |
107 | STAT1_20625510_ChIP-Seq_HELA_Human | 0.95865578 |
108 | AR_25329375_ChIP-Seq_VCAP_Human | 0.94490309 |
109 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.93932060 |
110 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 0.93797432 |
111 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.93528109 |
112 | SMAD4_21799915_ChIP-Seq_A2780_Human | 0.93506706 |
113 | SMAD1_18555785_Chip-Seq_ESCs_Mouse | 0.92855163 |
114 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 0.92774386 |
115 | RNF2_27304074_Chip-Seq_NSC_Mouse | 0.92435447 |
116 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.92225328 |
117 | STAT3_23295773_ChIP-Seq_U87_Human | 0.90971922 |
118 | FUS_26573619_Chip-Seq_HEK293_Human | 0.90477353 |
119 | * EGR1_23403033_ChIP-Seq_LIVER_Mouse | 0.90239506 |
120 | SPI1_23127762_ChIP-Seq_K562_Human | 0.89592930 |
121 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.89109991 |
122 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.87726972 |
123 | TAL1_26923725_Chip-Seq_HPCs_Mouse | 0.87586303 |
124 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.87139386 |
125 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.86859044 |
126 | ER_23166858_ChIP-Seq_MCF-7_Human | 0.86746884 |
127 | PU1_27457419_Chip-Seq_LIVER_Mouse | 0.86158857 |
128 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 0.86081201 |
129 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.86070655 |
130 | LMO2_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.85538328 |
131 | RUNX1_27457419_Chip-Seq_LIVER_Mouse | 0.84938607 |
132 | GATA3_26560356_Chip-Seq_TH2_Human | 0.84741919 |
133 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.84462947 |
134 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 0.84157941 |
135 | TP63_19390658_ChIP-ChIP_HaCaT_Human | 0.84114044 |
136 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 0.84007847 |
137 | P300_19829295_ChIP-Seq_ESCs_Human | 0.83908809 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0003303_peritoneal_inflammation | 6.15672118 |
2 | MP0002254_reproductive_system_inflammat | 5.28083545 |
3 | MP0001346_abnormal_lacrimal_gland | 4.70990143 |
4 | MP0004510_myositis | 3.83942514 |
5 | MP0005451_abnormal_body_composition | 3.75653293 |
6 | MP0008004_abnormal_stomach_pH | 3.71536465 |
7 | MP0000685_abnormal_immune_system | 3.46521882 |
8 | MP0002139_abnormal_hepatobiliary_system | 3.46187953 |
9 | MP0001835_abnormal_antigen_presentation | 3.35913093 |
10 | MP0005310_abnormal_salivary_gland | 3.23803573 |
11 | MP0002138_abnormal_hepatobiliary_system | 3.06188456 |
12 | MP0002102_abnormal_ear_morphology | 2.65217839 |
13 | MP0003195_calcinosis | 2.60898528 |
14 | MP0009785_altered_susceptibility_to | 2.57681874 |
15 | MP0003300_gastrointestinal_ulcer | 2.57570997 |
16 | MP0001790_abnormal_immune_system | 2.57460221 |
17 | MP0005387_immune_system_phenotype | 2.57460221 |
18 | MP0002277_abnormal_respiratory_mucosa | 2.50950831 |
19 | MP0003724_increased_susceptibility_to | 2.41917753 |
20 | MP0003718_maternal_effect | 2.37115848 |
21 | MP0003646_muscle_fatigue | 2.20460705 |
22 | MP0005671_abnormal_response_to | 2.15326139 |
23 | MP0002332_abnormal_exercise_endurance | 1.95444689 |
24 | MP0002148_abnormal_hypersensitivity_rea | 1.93746383 |
25 | MP0003453_abnormal_keratinocyte_physiol | 1.89203873 |
26 | MP0009840_abnormal_foam_cell | 1.88395821 |
27 | MP0000579_abnormal_nail_morphology | 1.86278329 |
28 | MP0002876_abnormal_thyroid_physiology | 1.78063266 |
29 | MP0006082_CNS_inflammation | 1.76656607 |
30 | MP0001348_abnormal_lacrimal_gland | 1.69924323 |
31 | MP0003075_altered_response_to | 1.69777038 |
32 | MP0005058_abnormal_lysosome_morphology | 1.69223838 |
33 | MP0001501_abnormal_sleep_pattern | 1.67533727 |
34 | MP0006054_spinal_hemorrhage | 1.61193513 |
35 | MP0000566_synostosis | 1.59035334 |
36 | MP0005025_abnormal_response_to | 1.58044413 |
37 | MP0003436_decreased_susceptibility_to | 1.56270564 |
38 | MP0005000_abnormal_immune_tolerance | 1.53548767 |
39 | MP0003693_abnormal_embryo_hatching | 1.51452290 |
40 | MP0008469_abnormal_protein_level | 1.50666815 |
41 | MP0001853_heart_inflammation | 1.50217349 |
42 | MP0002419_abnormal_innate_immunity | 1.49722236 |
43 | MP0002452_abnormal_antigen_presenting | 1.49239909 |
44 | MP0002163_abnormal_gland_morphology | 1.48982818 |
45 | MP0008007_abnormal_cellular_replicative | 1.47674741 |
46 | MP0001800_abnormal_humoral_immune | 1.47189795 |
47 | MP0005167_abnormal_blood-brain_barrier | 1.46020876 |
48 | MP0001119_abnormal_female_reproductive | 1.45383671 |
49 | MP0003656_abnormal_erythrocyte_physiolo | 1.39264958 |
50 | MP0002723_abnormal_immune_serum | 1.37405705 |
51 | MP0002006_tumorigenesis | 1.37025320 |
52 | MP0002735_abnormal_chemical_nociception | 1.34575078 |
53 | MP0004782_abnormal_surfactant_physiolog | 1.33413301 |
54 | MP0005166_decreased_susceptibility_to | 1.30626704 |
55 | MP0000427_abnormal_hair_cycle | 1.29693071 |
56 | MP0003868_abnormal_feces_composition | 1.28410418 |
57 | MP0005367_renal/urinary_system_phenotyp | 1.27100626 |
58 | MP0000516_abnormal_urinary_system | 1.27100626 |
59 | MP0005535_abnormal_body_temperature | 1.25464586 |
60 | MP0001819_abnormal_immune_cell | 1.23636126 |
61 | MP0002098_abnormal_vibrissa_morphology | 1.23219846 |
62 | MP0002877_abnormal_melanocyte_morpholog | 1.23204314 |
63 | MP0005395_other_phenotype | 1.22958818 |
64 | MP0000613_abnormal_salivary_gland | 1.22574743 |
65 | MP0000383_abnormal_hair_follicle | 1.21526599 |
66 | MP0010094_abnormal_chromosome_stability | 1.21461788 |
67 | MP0009764_decreased_sensitivity_to | 1.20860987 |
68 | MP0004264_abnormal_extraembryonic_tissu | 1.19965415 |
69 | MP0002420_abnormal_adaptive_immunity | 1.19814659 |
70 | MP0003763_abnormal_thymus_physiology | 1.19442720 |
71 | MP0000858_altered_metastatic_potential | 1.18364540 |
72 | MP0004947_skin_inflammation | 1.17268359 |
73 | MP0002405_respiratory_system_inflammati | 1.15118100 |
74 | MP0005165_increased_susceptibility_to | 1.14575500 |
75 | MP0000627_abnormal_mammary_gland | 1.14530569 |
76 | MP0005408_hypopigmentation | 1.14477185 |
77 | MP0010155_abnormal_intestine_physiology | 1.14447734 |
78 | MP0000538_abnormal_urinary_bladder | 1.13100979 |
79 | MP0003699_abnormal_female_reproductive | 1.11910086 |
80 | MP0001545_abnormal_hematopoietic_system | 1.10919303 |
81 | MP0005397_hematopoietic_system_phenotyp | 1.10919303 |
82 | MP0001986_abnormal_taste_sensitivity | 1.09968075 |
83 | MP0009763_increased_sensitivity_to | 1.07762510 |
84 | MP0001845_abnormal_inflammatory_respons | 1.07595186 |
85 | MP0001663_abnormal_digestive_system | 1.06793063 |
86 | MP0002249_abnormal_larynx_morphology | 1.04030914 |
87 | MP0001851_eye_inflammation | 1.01353358 |
88 | MP0005647_abnormal_sex_gland | 1.01312786 |
89 | MP0010386_abnormal_urinary_bladder | 1.01050638 |
90 | MP0002998_abnormal_bone_remodeling | 0.99596297 |
91 | MP0003690_abnormal_glial_cell | 0.98703572 |
92 | * MP0000716_abnormal_immune_system | 0.98375423 |
93 | MP0005164_abnormal_response_to | 0.97517014 |
94 | MP0000604_amyloidosis | 0.97319183 |
95 | MP0002693_abnormal_pancreas_physiology | 0.96920728 |
96 | MP0009278_abnormal_bone_marrow | 0.95648361 |
97 | MP0001542_abnormal_bone_strength | 0.95128422 |
98 | MP0003091_abnormal_cell_migration | 0.94255299 |
99 | MP0009250_abnormal_appendicular_skeleto | 0.94034365 |
100 | MP0003448_altered_tumor_morphology | 0.92519714 |
101 | MP0000678_abnormal_parathyroid_gland | 0.92110603 |
102 | MP0003937_abnormal_limbs/digits/tail_de | 0.91889638 |
103 | MP0002398_abnormal_bone_marrow | 0.90896117 |
104 | MP0001533_abnormal_skeleton_physiology | 0.90540462 |
105 | MP0009333_abnormal_splenocyte_physiolog | 0.89444613 |
106 | MP0005379_endocrine/exocrine_gland_phen | 0.89165496 |
107 | MP0000733_abnormal_muscle_development | 0.88878356 |
108 | MP0003077_abnormal_cell_cycle | 0.88109775 |
109 | MP0006292_abnormal_olfactory_placode | 0.87788915 |
110 | MP0003806_abnormal_nucleotide_metabolis | 0.84511524 |
111 | MP0003172_abnormal_lysosome_physiology | 0.83575964 |
112 | MP0005390_skeleton_phenotype | 0.83429990 |
113 | MP0002177_abnormal_outer_ear | 0.82518925 |
114 | MP0001919_abnormal_reproductive_system | 0.81563333 |
115 | MP0005448_abnormal_energy_balance | 0.80634074 |
116 | MP0004185_abnormal_adipocyte_glucose | 0.80536758 |
117 | MP0001216_abnormal_epidermal_layer | 0.80384589 |
118 | MP0002396_abnormal_hematopoietic_system | 0.79935972 |
119 | MP0005023_abnormal_wound_healing | 0.79731209 |
120 | MP0001849_ear_inflammation | 0.79601080 |
121 | MP0009765_abnormal_xenobiotic_induced | 0.79596614 |
122 | MP0003705_abnormal_hypodermis_morpholog | 0.79423643 |
123 | MP0003045_fibrosis | 0.79370760 |
124 | MP0004043_abnormal_pH_regulation | 0.79257046 |
125 | MP0010678_abnormal_skin_adnexa | 0.78781719 |
126 | MP0003941_abnormal_skin_development | 0.78563688 |
127 | MP0001881_abnormal_mammary_gland | 0.77190898 |
128 | MP0003950_abnormal_plasma_membrane | 0.76836850 |
129 | MP0008874_decreased_physiological_sensi | 0.76815290 |
130 | MP0001873_stomach_inflammation | 0.75114631 |
131 | MP0003866_abnormal_defecation | 0.74795368 |
132 | MP0000569_abnormal_digit_pigmentation | 0.73897287 |
133 | MP0003183_abnormal_peptide_metabolism | 0.72486504 |
134 | MP0003566_abnormal_cell_adhesion | 0.71447888 |
135 | * MP0000689_abnormal_spleen_morphology | 0.70407765 |
136 | MP0002837_dystrophic_cardiac_calcinosis | 0.69778922 |
137 | MP0005365_abnormal_bile_salt | 0.69574432 |
138 | MP0001764_abnormal_homeostasis | 0.68799083 |
139 | MP0005266_abnormal_metabolism | 0.68214122 |
140 | MP0000343_altered_response_to | 0.68188652 |
141 | * MP0002429_abnormal_blood_cell | 0.67779049 |
142 | MP0000465_gastrointestinal_hemorrhage | 0.66453828 |
143 | MP0000609_abnormal_liver_physiology | 0.65954200 |
144 | MP0000249_abnormal_blood_vessel | 0.65140093 |
145 | MP0008789_abnormal_olfactory_epithelium | 0.64779938 |
146 | MP0005464_abnormal_platelet_physiology | 0.64683747 |
147 | MP0005381_digestive/alimentary_phenotyp | 0.64295347 |
148 | MP0002136_abnormal_kidney_physiology | 0.62858470 |
149 | MP0005666_abnormal_adipose_tissue | 0.62815102 |
150 | MP0002095_abnormal_skin_pigmentation | 0.62545679 |
151 | MP0003191_abnormal_cellular_cholesterol | 0.61605908 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Abnormality of glycolipid metabolism (HP:0010969) | 4.79167391 |
2 | Abnormality of liposaccharide metabolism (HP:0010968) | 4.79167391 |
3 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 4.79167391 |
4 | Lip pit (HP:0100267) | 4.65217733 |
5 | Stomatitis (HP:0010280) | 4.17159711 |
6 | Optic neuritis (HP:0100653) | 4.07238530 |
7 | Retrobulbar optic neuritis (HP:0100654) | 4.07238530 |
8 | Prostate neoplasm (HP:0100787) | 3.96761958 |
9 | Abnormal respiratory motile cilium morphology (HP:0005938) | 3.90042479 |
10 | Abnormal respiratory epithelium morphology (HP:0012253) | 3.90042479 |
11 | Vacuolated lymphocytes (HP:0001922) | 3.79628723 |
12 | Eczematoid dermatitis (HP:0000976) | 3.76460844 |
13 | Systemic lupus erythematosus (HP:0002725) | 3.70713973 |
14 | Orchitis (HP:0100796) | 3.69473156 |
15 | Abnormality of the fingertips (HP:0001211) | 3.63652196 |
16 | Recurrent abscess formation (HP:0002722) | 3.57128095 |
17 | Loss of speech (HP:0002371) | 3.50677103 |
18 | Chronic sinusitis (HP:0011109) | 3.42844930 |
19 | Autoimmune thrombocytopenia (HP:0001973) | 3.38731142 |
20 | Recurrent bacterial skin infections (HP:0005406) | 3.37251929 |
21 | Myositis (HP:0100614) | 3.35876155 |
22 | Chromsome breakage (HP:0040012) | 3.35532457 |
23 | Disinhibition (HP:0000734) | 3.27641343 |
24 | Tetraparesis (HP:0002273) | 3.26888978 |
25 | Recurrent sinusitis (HP:0011108) | 3.15390992 |
26 | Male infertility (HP:0003251) | 3.06225132 |
27 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 3.05960817 |
28 | Absent/shortened dynein arms (HP:0200106) | 3.05297067 |
29 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 3.05297067 |
30 | Dysostosis multiplex (HP:0000943) | 3.05091782 |
31 | Petechiae (HP:0000967) | 2.98792689 |
32 | Natal tooth (HP:0000695) | 2.91563374 |
33 | Anhidrosis (HP:0000970) | 2.91474722 |
34 | Adrenal hypoplasia (HP:0000835) | 2.88789884 |
35 | Milia (HP:0001056) | 2.86013983 |
36 | Nasolacrimal duct obstruction (HP:0000579) | 2.81000407 |
37 | Recurrent cutaneous fungal infections (HP:0011370) | 2.80980359 |
38 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.80980359 |
39 | Purpura (HP:0000979) | 2.79767510 |
40 | Papillary thyroid carcinoma (HP:0002895) | 2.79339321 |
41 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 2.77915580 |
42 | Increased IgM level (HP:0003496) | 2.76822719 |
43 | Joint swelling (HP:0001386) | 2.76683749 |
44 | Increased cerebral lipofuscin (HP:0011813) | 2.76013746 |
45 | Mutism (HP:0002300) | 2.75658289 |
46 | Nuclear cataract (HP:0100018) | 2.71161600 |
47 | Periodontitis (HP:0000704) | 2.68466496 |
48 | Glomerulonephritis (HP:0000099) | 2.67273044 |
49 | Vertebral compression fractures (HP:0002953) | 2.66253410 |
50 | Gangrene (HP:0100758) | 2.63806188 |
51 | Hematochezia (HP:0002573) | 2.62515633 |
52 | Keratoconjunctivitis (HP:0001096) | 2.61012533 |
53 | Acute myeloid leukemia (HP:0004808) | 2.59359675 |
54 | Inappropriate behavior (HP:0000719) | 2.57935165 |
55 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.56902074 |
56 | Recurrent skin infections (HP:0001581) | 2.55662214 |
57 | Vasculitis (HP:0002633) | 2.55609361 |
58 | Flat capital femoral epiphysis (HP:0003370) | 2.52015188 |
59 | Onycholysis (HP:0001806) | 2.51000958 |
60 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.47707669 |
61 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.47707669 |
62 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.47707669 |
63 | Arterial thrombosis (HP:0004420) | 2.47252478 |
64 | Spontaneous abortion (HP:0005268) | 2.44925410 |
65 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.44764215 |
66 | Aplasia cutis congenita (HP:0001057) | 2.39673832 |
67 | Microretrognathia (HP:0000308) | 2.37858094 |
68 | Increased serum ferritin (HP:0003281) | 2.37564064 |
69 | Chronic otitis media (HP:0000389) | 2.36702106 |
70 | Mixed hearing impairment (HP:0000410) | 2.36123246 |
71 | Mucopolysacchariduria (HP:0008155) | 2.35876011 |
72 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.35876011 |
73 | Gastrointestinal stroma tumor (HP:0100723) | 2.34414507 |
74 | Encephalitis (HP:0002383) | 2.33725456 |
75 | Alveolar cell carcinoma (HP:0006519) | 2.31548104 |
76 | Plantar hyperkeratosis (HP:0007556) | 2.31528959 |
77 | Type 2 muscle fiber atrophy (HP:0003554) | 2.30401819 |
78 | Mediastinal lymphadenopathy (HP:0100721) | 2.29674984 |
79 | Recurrent bronchitis (HP:0002837) | 2.29461818 |
80 | Premature loss of primary teeth (HP:0006323) | 2.29430420 |
81 | Prolonged bleeding time (HP:0003010) | 2.27914381 |
82 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.27305124 |
83 | IgA deficiency (HP:0002720) | 2.26671590 |
84 | Metaphyseal irregularity (HP:0003025) | 2.26556867 |
85 | Thoracolumbar scoliosis (HP:0002944) | 2.24724566 |
86 | Neoplasm of the tracheobronchial system (HP:0100552) | 2.23883917 |
87 | Periauricular skin pits (HP:0100277) | 2.23652038 |
88 | Preauricular pit (HP:0004467) | 2.23652038 |
89 | Capillary hemangiomas (HP:0005306) | 2.23012972 |
90 | Recurrent fungal infections (HP:0002841) | 2.21539130 |
91 | Polyneuropathy (HP:0001271) | 2.21241768 |
92 | Keratoconjunctivitis sicca (HP:0001097) | 2.21184282 |
93 | Hypergammaglobulinemia (HP:0010702) | 2.18826341 |
94 | Abnormality of the lacrimal duct (HP:0011481) | 2.18548867 |
95 | Abnormal ciliary motility (HP:0012262) | 2.18485323 |
96 | Congenital sensorineural hearing impairment (HP:0008527) | 2.18277195 |
97 | Protruding tongue (HP:0010808) | 2.17200152 |
98 | Abnormality of the prostate (HP:0008775) | 2.16464221 |
99 | Interstitial pulmonary disease (HP:0006530) | 2.16076890 |
100 | Clubbing of toes (HP:0100760) | 2.15856641 |
101 | Abnormality of iron homeostasis (HP:0011031) | 2.14840061 |
102 | Intrahepatic cholestasis (HP:0001406) | 2.12471768 |
103 | Atrophic scars (HP:0001075) | 2.12189237 |
104 | Gastrointestinal infarctions (HP:0005244) | 2.11433777 |
105 | Nausea (HP:0002018) | 2.11077099 |
106 | Autoimmune hemolytic anemia (HP:0001890) | 2.10213091 |
107 | Abnormality of the neuromuscular junction (HP:0003398) | 2.09820401 |
108 | Fatigable weakness (HP:0003473) | 2.09820401 |
109 | Pulmonary infiltrates (HP:0002113) | 2.08166553 |
110 | Hypergonadotropic hypogonadism (HP:0000815) | 2.08082032 |
111 | Abnormality of B cell number (HP:0010975) | 2.07996929 |
112 | Abnormality of macrophages (HP:0004311) | 2.06186585 |
113 | Colitis (HP:0002583) | 2.05976167 |
114 | Muscle fiber atrophy (HP:0100295) | 2.05920781 |
115 | Patellar aplasia (HP:0006443) | 2.05279987 |
116 | Ventricular fibrillation (HP:0001663) | 2.03411131 |
117 | Arterial tortuosity (HP:0005116) | 2.02296343 |
118 | Bronchiectasis (HP:0002110) | 2.01176134 |
119 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.98000471 |
120 | Albinism (HP:0001022) | 1.97997601 |
121 | Shawl scrotum (HP:0000049) | 1.96196939 |
122 | Abnormal respiratory motile cilium physiology (HP:0012261) | 1.95058666 |
123 | Pustule (HP:0200039) | 1.94921315 |
124 | Acne (HP:0001061) | 1.94734894 |
125 | Abnormality of incisor morphology (HP:0011063) | 1.93268547 |
126 | Progressive neurologic deterioration (HP:0002344) | 1.92789605 |
127 | Keratitis (HP:0000491) | 1.92653226 |
128 | Cortical dysplasia (HP:0002539) | 1.92593326 |
129 | Hemoptysis (HP:0002105) | 1.91410514 |
130 | Absent hand (HP:0004050) | 1.90385634 |
131 | Thrombocytosis (HP:0001894) | 1.90228429 |
132 | Abnormality of male internal genitalia (HP:0000022) | 1.90061334 |
133 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 1.89738755 |
134 | Chronic diarrhea (HP:0002028) | 1.89389599 |
135 | Xerostomia (HP:0000217) | 1.89002962 |
136 | Elevated erythrocyte sedimentation rate (HP:0003565) | 1.88716458 |
137 | Hyperventilation (HP:0002883) | 1.88425522 |
138 | Hypoplasia of dental enamel (HP:0006297) | 1.87955278 |
139 | Aplasia/Hypoplasia of the patella (HP:0006498) | 1.87829399 |
140 | Abnormality of the preputium (HP:0100587) | 1.86846268 |
141 | Respiratory insufficiency due to defective ciliary clearance (HP:0200073) | 1.86335955 |
142 | Pulmonary fibrosis (HP:0002206) | 1.86274104 |
143 | Complement deficiency (HP:0004431) | 1.85794737 |
144 | Generalized aminoaciduria (HP:0002909) | 1.85545370 |
145 | Abnormality of the nasal mucosa (HP:0000433) | 1.84815088 |
146 | Cleft eyelid (HP:0000625) | 1.83227550 |
147 | Recurrent viral infections (HP:0004429) | 1.82032656 |
148 | Abnormality of the labia minora (HP:0012880) | 1.81494303 |
149 | Abnormality of the pleura (HP:0002103) | 1.79286795 |
150 | Emphysema (HP:0002097) | 1.78791004 |
151 | Basal ganglia calcification (HP:0002135) | 1.78609992 |
152 | Nail dystrophy (HP:0008404) | 1.78470100 |
153 | Thick nail (HP:0001805) | 1.78391951 |
154 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 1.78079476 |
155 | Arthralgia (HP:0002829) | 1.77050425 |
156 | Tetany (HP:0001281) | 1.75776217 |
157 | Malnutrition (HP:0004395) | 1.75158987 |
158 | Dry hair (HP:0011359) | 1.74989615 |
159 | Abnormality of the pericardium (HP:0001697) | 1.74690488 |
160 | Abnormality of T cell number (HP:0011839) | 1.74545503 |
161 | Esophageal varix (HP:0002040) | 1.74150058 |
162 | Recurrent pneumonia (HP:0006532) | 1.73427764 |
163 | Aseptic necrosis (HP:0010885) | 1.72652374 |
164 | Insulin-resistant diabetes mellitus (HP:0000831) | 1.72480689 |
165 | Aplasia/Hypoplasia of the uvula (HP:0010293) | 1.71659711 |
166 | Vascular tortuosity (HP:0004948) | 1.70700849 |
167 | Parakeratosis (HP:0001036) | 1.69375896 |
168 | Weak cry (HP:0001612) | 1.69243209 |
169 | Fibular aplasia (HP:0002990) | 1.68093621 |
170 | Skin pits (HP:0100276) | 1.68076726 |
171 | Pili torti (HP:0003777) | 1.67692490 |
172 | Nasal polyposis (HP:0100582) | 1.66083819 |
173 | Abnormality of the gastric mucosa (HP:0004295) | 1.63703145 |
174 | Recurrent lower respiratory tract infections (HP:0002783) | 1.63534277 |
175 | Porencephaly (HP:0002132) | 1.62204584 |
176 | Facial hemangioma (HP:0000329) | 1.62186673 |
Rank | Gene Set | Z-score |
---|---|---|
1 | CASK | 4.21546307 |
2 | LATS1 | 3.86890736 |
3 | MAP3K13 | 3.49318162 |
4 | GRK7 | 3.21436819 |
5 | MAP3K14 | 2.90012565 |
6 | STK38L | 2.85842426 |
7 | TAOK3 | 2.72963740 |
8 | ERBB4 | 2.71190418 |
9 | MUSK | 2.66000613 |
10 | PLK4 | 2.65544750 |
11 | IKBKE | 2.62186193 |
12 | MAP3K6 | 2.60826944 |
13 | JAK3 | 2.53960954 |
14 | LATS2 | 2.52248266 |
15 | ARAF | 2.32786667 |
16 | BMPR2 | 2.32031186 |
17 | TYK2 | 2.26936385 |
18 | DDR2 | 2.26556263 |
19 | KSR2 | 2.12223205 |
20 | MAPKAPK3 | 2.11886761 |
21 | FRK | 2.08489074 |
22 | BRAF | 2.04112367 |
23 | IKBKB | 2.03240998 |
24 | MOS | 2.01225556 |
25 | STK3 | 2.00642160 |
26 | CHUK | 1.94869677 |
27 | TAOK2 | 1.87997029 |
28 | RAF1 | 1.84176868 |
29 | NME2 | 1.82683158 |
30 | NUAK1 | 1.81838394 |
31 | RPS6KA4 | 1.76488870 |
32 | TBK1 | 1.76035889 |
33 | RIPK4 | 1.75234120 |
34 | IRAK1 | 1.74497976 |
35 | EEF2K | 1.71375112 |
36 | MAP4K1 | 1.67809821 |
37 | KIT | 1.51814749 |
38 | RIPK1 | 1.50129831 |
39 | INSRR | 1.48964274 |
40 | CDK8 | 1.48167625 |
41 | TRPM7 | 1.47436569 |
42 | MAP3K9 | 1.46377781 |
43 | NLK | 1.45464241 |
44 | TAOK1 | 1.35850274 |
45 | BMPR1B | 1.33242316 |
46 | TTK | 1.31920963 |
47 | IRAK2 | 1.29796474 |
48 | MST4 | 1.28687308 |
49 | ADRBK2 | 1.23715687 |
50 | MAP2K6 | 1.23012106 |
51 | CDC42BPA | 1.14636205 |
52 | JAK1 | 1.11390674 |
53 | IRAK4 | 1.08180767 |
54 | LYN | 1.05806362 |
55 | TGFBR2 | 1.04076580 |
56 | ABL2 | 1.01169146 |
57 | SYK | 1.01044122 |
58 | CHEK2 | 0.98713736 |
59 | MAP3K11 | 0.98200655 |
60 | MELK | 0.97932986 |
61 | STK10 | 0.96424111 |
62 | RPS6KB2 | 0.95673910 |
63 | CSK | 0.94262726 |
64 | MAP2K3 | 0.92605965 |
65 | CDK9 | 0.89940441 |
66 | CSF1R | 0.89739841 |
67 | PRKAA2 | 0.89558455 |
68 | TNIK | 0.89272034 |
69 | MAP3K12 | 0.88803423 |
70 | MAPKAPK5 | 0.88028079 |
71 | PKN1 | 0.87760131 |
72 | LMTK2 | 0.87410063 |
73 | STK24 | 0.85519751 |
74 | MAP3K3 | 0.83438340 |
75 | TEC | 0.81713342 |
76 | DAPK2 | 0.77912277 |
77 | EPHA3 | 0.76261083 |
78 | PIM1 | 0.75553163 |
79 | EIF2AK2 | 0.75115975 |
80 | DYRK3 | 0.74293963 |
81 | ZAP70 | 0.73717754 |
82 | DMPK | 0.71750826 |
83 | VRK1 | 0.71664440 |
84 | CDK12 | 0.71101054 |
85 | ZAK | 0.70432220 |
86 | PRPF4B | 0.67879025 |
87 | PAK6 | 0.67776578 |
88 | DYRK2 | 0.66147000 |
89 | MAP3K1 | 0.65082265 |
90 | JAK2 | 0.63902274 |
91 | IRAK3 | 0.62449970 |
92 | CDK3 | 0.59255548 |
93 | MARK3 | 0.58701006 |
94 | BMX | 0.56480355 |
95 | KSR1 | 0.55422238 |
96 | MAP3K5 | 0.53538016 |
97 | BLK | 0.52498895 |
98 | ABL1 | 0.52138553 |
99 | STK4 | 0.50978217 |
100 | CAMKK2 | 0.50424001 |
101 | MAP3K8 | 0.49347177 |
102 | MAPK13 | 0.48744020 |
103 | PRKCQ | 0.47822430 |
104 | PIM2 | 0.46298092 |
105 | BCR | 0.45210224 |
106 | PDGFRA | 0.43040490 |
107 | PRKG2 | 0.42601326 |
108 | MAPK7 | 0.41261381 |
109 | PBK | 0.40648997 |
110 | PRKAA1 | 0.40135644 |
111 | PLK1 | 0.38903159 |
112 | NME1 | 0.38427696 |
113 | EGFR | 0.37433404 |
114 | MAPK4 | 0.36816747 |
115 | CDK4 | 0.36587437 |
116 | MAP4K2 | 0.36145898 |
117 | PINK1 | 0.35847215 |
118 | NEK9 | 0.35520383 |
119 | MAPK15 | 0.35396486 |
120 | ERBB3 | 0.35244508 |
121 | NEK2 | 0.34951937 |
122 | EPHB1 | 0.34601290 |
123 | MAPK11 | 0.33401195 |
124 | PLK2 | 0.33049140 |
125 | TLK1 | 0.32850894 |
126 | EPHA2 | 0.32187940 |
127 | PLK3 | 0.31776410 |
128 | CDK6 | 0.31751897 |
129 | MAPKAPK2 | 0.31718476 |
130 | RPS6KA5 | 0.31026074 |
131 | TXK | 0.30866326 |
132 | CLK1 | 0.29995335 |
133 | PTK2B | 0.29577864 |
134 | PDGFRB | 0.29335949 |
135 | PRKCE | 0.28592126 |
136 | FGR | 0.27931782 |
137 | HCK | 0.27890971 |
138 | AURKB | 0.27315591 |
139 | MATK | 0.26958347 |
140 | ACVR1B | 0.26785401 |
141 | ERN1 | 0.26508648 |
142 | MAP3K4 | 0.26327733 |
143 | BTK | 0.26315306 |
144 | STK39 | 0.25214793 |
145 | ICK | 0.25043970 |
146 | ATM | 0.23668791 |
147 | EPHB2 | 0.22130843 |
148 | PRKD2 | 0.21942564 |
149 | HIPK2 | 0.21462328 |
150 | MAP2K1 | 0.20015583 |
151 | SIK3 | 0.17160458 |
152 | LCK | 0.16077978 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Asthma_Homo sapiens_hsa05310 | 3.83678761 |
2 | Leishmaniasis_Homo sapiens_hsa05140 | 2.49613783 |
3 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.46178725 |
4 | Allograft rejection_Homo sapiens_hsa05330 | 2.44472507 |
5 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 2.35489728 |
6 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.26829956 |
7 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.25896212 |
8 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 2.21145277 |
9 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 2.20311958 |
10 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.16619131 |
11 | Influenza A_Homo sapiens_hsa05164 | 2.10362779 |
12 | Herpes simplex infection_Homo sapiens_hsa05168 | 2.03579334 |
13 | Measles_Homo sapiens_hsa05162 | 2.03399486 |
14 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.97164614 |
15 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.86862966 |
16 | * Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.76473527 |
17 | p53 signaling pathway_Homo sapiens_hsa04115 | 1.72442487 |
18 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.71104598 |
19 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 1.65090199 |
20 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.64844243 |
21 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 1.63547032 |
22 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.61226530 |
23 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.56079151 |
24 | Ether lipid metabolism_Homo sapiens_hsa00565 | 1.54084651 |
25 | Malaria_Homo sapiens_hsa05144 | 1.53782385 |
26 | Basal transcription factors_Homo sapiens_hsa03022 | 1.50732325 |
27 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.49525516 |
28 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.48153543 |
29 | Lysosome_Homo sapiens_hsa04142 | 1.46997061 |
30 | * Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.46433778 |
31 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.45586372 |
32 | Cell cycle_Homo sapiens_hsa04110 | 1.45348701 |
33 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.42968976 |
34 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.35403530 |
35 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 1.32947565 |
36 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.32305418 |
37 | Legionellosis_Homo sapiens_hsa05134 | 1.31147635 |
38 | Pertussis_Homo sapiens_hsa05133 | 1.28589976 |
39 | RNA degradation_Homo sapiens_hsa03018 | 1.25471638 |
40 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.25059113 |
41 | Tuberculosis_Homo sapiens_hsa05152 | 1.23031739 |
42 | Circadian rhythm_Homo sapiens_hsa04710 | 1.21192536 |
43 | Shigellosis_Homo sapiens_hsa05131 | 1.21065645 |
44 | Hepatitis B_Homo sapiens_hsa05161 | 1.20310192 |
45 | Apoptosis_Homo sapiens_hsa04210 | 1.16033952 |
46 | Small cell lung cancer_Homo sapiens_hsa05222 | 1.10930747 |
47 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.10060708 |
48 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.07613034 |
49 | Salmonella infection_Homo sapiens_hsa05132 | 1.05627063 |
50 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.98431740 |
51 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.97213275 |
52 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.95709577 |
53 | Hepatitis C_Homo sapiens_hsa05160 | 0.95413588 |
54 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.91474297 |
55 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.90516393 |
56 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.87623001 |
57 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.85966821 |
58 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.85851394 |
59 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.85670791 |
60 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.83278365 |
61 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.82938273 |
62 | Amoebiasis_Homo sapiens_hsa05146 | 0.82864403 |
63 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.81039700 |
64 | ABC transporters_Homo sapiens_hsa02010 | 0.80654031 |
65 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.79087648 |
66 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.79042386 |
67 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.78148245 |
68 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.76783351 |
69 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.76158557 |
70 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.75693369 |
71 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.73488701 |
72 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.73194553 |
73 | Adherens junction_Homo sapiens_hsa04520 | 0.72767514 |
74 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.72704680 |
75 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.71164873 |
76 | Homologous recombination_Homo sapiens_hsa03440 | 0.71040849 |
77 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.70705070 |
78 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.68731124 |
79 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.68430087 |
80 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.67873010 |
81 | * Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.67239406 |
82 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.64180632 |
83 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.63810951 |
84 | Prion diseases_Homo sapiens_hsa05020 | 0.63049306 |
85 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.61815409 |
86 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.59783268 |
87 | Mineral absorption_Homo sapiens_hsa04978 | 0.59484706 |
88 | Phagosome_Homo sapiens_hsa04145 | 0.58966560 |
89 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.56947592 |
90 | HTLV-I infection_Homo sapiens_hsa05166 | 0.55734000 |
91 | Thyroid cancer_Homo sapiens_hsa05216 | 0.54457361 |
92 | Viral myocarditis_Homo sapiens_hsa05416 | 0.54151158 |
93 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.53644407 |
94 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.51172255 |
95 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.50955629 |
96 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.50599116 |
97 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.50462700 |
98 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.49706447 |
99 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.46208170 |
100 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.46124867 |
101 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.43898608 |
102 | Other glycan degradation_Homo sapiens_hsa00511 | 0.43344360 |
103 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.43117638 |
104 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.42467916 |
105 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.41394754 |
106 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.41310629 |
107 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.41112543 |
108 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.41048301 |
109 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.40408629 |
110 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.40217008 |
111 | Pathways in cancer_Homo sapiens_hsa05200 | 0.39368578 |
112 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.38570350 |
113 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.38280217 |
114 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.37831325 |
115 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.37247707 |
116 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.36957966 |
117 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.34712321 |
118 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.33482937 |
119 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.33384279 |
120 | Prostate cancer_Homo sapiens_hsa05215 | 0.31687821 |
121 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.31244269 |
122 | Colorectal cancer_Homo sapiens_hsa05210 | 0.30570343 |
123 | Melanoma_Homo sapiens_hsa05218 | 0.29047304 |
124 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.27830875 |
125 | Platelet activation_Homo sapiens_hsa04611 | 0.27683769 |
126 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.27315413 |
127 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.25656573 |
128 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.25025498 |
129 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.24747669 |
130 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.23587945 |
131 | Insulin resistance_Homo sapiens_hsa04931 | 0.22639009 |
132 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.22025987 |
133 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.21295029 |
134 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.20029377 |
135 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.19817441 |